| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
25,230,000 |
| Market
Cap: |
298.98(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$4.8 - $14.07 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Verastem is a late stage development biopharmaceutical company, with ongoing registration directed trials, focused on developing and commercializing medicines for patients battling cancer. Co.'s product candidates, VS-6766 and defactinib, are being investigated in both preclinical and clinical studies for the treatment of various solid tumors. VS-6766 is an orally available small molecule rapidly accelerated fibrosarcoma/ mitogen-activated protein kinase kinase clamp. Defactinib is an oral small molecule inhibitor of Focal Adhesion Kinase and proline-rich tyrosine kinase that is being evaluated as a potential combination therapy for various solid tumors.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
1,735 |
21,833 |
25,311 |
165,018 |
| Total Sell Value |
$18,442 |
$258,319 |
$292,764 |
$385,800 |
| Total People Sold |
4 |
4 |
4 |
4 |
| Total Sell Transactions |
9 |
20 |
37 |
63 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Singh Monica |
General Counsel |
• – – |
2014-12-23 |
4 |
B |
$8.09 |
$8,089 |
D/D |
1,000 |
1,000 |
2.74 |
- |
|
| Westphal Christoph H |
Executive Chairman |
• • – |
2014-12-19 |
4 |
B |
$8.50 |
$12,750 |
D/D |
1,500 |
687,016 |
2.81 |
- |
|
| Paterson Dan |
Chief Operating Officer |
• – – |
2014-12-19 |
4 |
B |
$8.52 |
$17,040 |
D/D |
2,000 |
45,857 |
2.74 |
- |
|
| Forrester Robert |
President and CEO |
• • – |
2014-12-19 |
4 |
B |
$8.66 |
$8,660 |
D/D |
1,000 |
232,114 |
2.81 |
- |
|
| Lawton Alison Francis |
Director |
– • – |
2014-11-11 |
4 |
B |
$9.17 |
$22,923 |
D/D |
2,500 |
2,500 |
2.39 |
- |
|
| Westphal Christoph H |
Executive Chairman |
• • – |
2014-09-30 |
4 |
D |
$8.60 |
$23,753 |
D/D |
(2,762) |
685,516 |
|
- |
|
| Kauffman Michael |
Director |
– • – |
2014-09-17 |
4 |
B |
$9.10 |
$27,300 |
D/D |
3,000 |
3,000 |
2.39 |
- |
|
| Pachter Jonathan |
VP, Head of Research |
• – – |
2014-08-01 |
4 |
D |
$7.39 |
$34,777 |
D/D |
(4,706) |
62,249 |
|
- |
|
| Forrester Robert |
President & CEO |
• • – |
2014-08-01 |
4 |
D |
$7.39 |
$60,642 |
D/D |
(8,206) |
231,114 |
|
- |
|
| Paterson Dan |
Cheif Business Officer |
• – – |
2014-08-01 |
4 |
D |
$7.39 |
$47,096 |
D/D |
(6,373) |
43,857 |
|
- |
|
| Westphal Christoph H |
Executive Chairman |
• • – |
2014-06-30 |
4 |
D |
$9.52 |
$52,646 |
D/D |
(5,530) |
694,734 |
|
- |
|
| Barberich Timothy J |
Director |
– • – |
2014-05-30 |
4 |
B |
$9.90 |
$9,895 |
D/D |
1,000 |
1,000 |
2.39 |
- |
|
| Aldrich Richard |
Director |
– • – |
2014-05-20 |
4 |
B |
$8.37 |
$8,370 |
D/D |
1,000 |
408,142 |
2.39 |
- |
|
| Paterson Dan |
Chief Business Officer |
• – – |
2014-05-15 |
4 |
B |
$7.47 |
$7,467 |
D/D |
1,000 |
58,143 |
2.74 |
- |
|
| Westphal Christoph H |
Executive Chairman |
• • – |
2014-05-14 |
4 |
B |
$7.56 |
$15,120 |
D/D |
2,000 |
700,264 |
2.81 |
- |
|
| Green John B |
Chief Financial Officer |
• – – |
2014-05-13 |
4 |
B |
$7.74 |
$7,740 |
D/D |
1,000 |
1,000 |
2.74 |
- |
|
| Pachter Jonathan |
VP, Head of Research |
• – – |
2014-05-13 |
4 |
B |
$7.62 |
$7,620 |
D/D |
1,000 |
66,955 |
2.74 |
- |
|
| Forrester Robert |
President and CEO |
• • – |
2014-05-13 |
4 |
B |
$7.62 |
$7,620 |
D/D |
1,000 |
239,320 |
2.81 |
- |
|
168 Records found
|
|
Page 7 of 7 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.07 (0.59%) 
